Ascendis Pharma A/S
ASND · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$61 | -$39 | -$95 | -$38 |
| Dep. & Amort. | $4 | $4 | $5 | $4 |
| Deferred Tax | $4 | $4 | $1 | $1 |
| Stock-Based Comp. | $31 | $30 | $26 | $26 |
| Change in WC | $25 | -$44 | $50 | -$44 |
| Other Non-Cash | $0 | $37 | -$1 | -$36 |
| Operating Cash Flow | $2 | -$7 | -$14 | -$87 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$4 | -$1 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | -$0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | -$4 | -$1 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$7 | -$5 | -$3 | -$3 |
| Stock Issued | $0 | $0 | $0 | $19 |
| Stock Repurch. | $0 | $0 | -$17 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $45 | $12 | $2 | -$16 |
| Financing Cash Flow | $39 | $7 | -$18 | $0 |
| Forex Effect | $4 | -$19 | -$9 | $22 |
| Net Chg. in Cash | $45 | -$24 | -$42 | -$66 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $494 | $518 | $560 | $626 |
| End Cash | $539 | $494 | $518 | $560 |
| Free Cash Flow | $2 | -$12 | -$15 | -$88 |